Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight‐based dose of insulin Aspart

References

• American Diabetes Association. Postprandial blood glucose. Diabetes Care 2001; 24: 775–8
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53
   PubMed Web of Science ®Google Scholar
• Hanefeld M., Fischer S., Julius U., Schulze J., Schwanebeck U., Schmechel H., et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11‐year follow‐up. Diabetologia 1996; 39: 1577–83
   PubMed Web of Science ®Google Scholar
• Temelkova‐Kurktschiev T. S., Koehler C., Henkel E., Leonhardt W., Fuecker K., Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000; 23: 1830–4
   PubMed Web of Science ®Google Scholar
• The DECODE study group. European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 1999; 354: 617–21
   PubMed Web of Science ®Google Scholar
• Peter R., Luzio S. D., Dunseath G., Pauvaday V., Mustafa N., Owens D. R. Relationship between HbA1c and indices of glucose tolerance derived from a standardized meal test in newly diagnosed treatment naive subjects with Type 2 diabetes. Diabet Med 2006; 23: 990–5
   PubMed Web of Science ®Google Scholar
• Monnier L., Lapinski H., Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003; 26: 881–5
   PubMed Web of Science ®Google Scholar
• DeFronzo R. A., Bonadonna R. C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318–68
   PubMed Web of Science ®Google Scholar
• Gredal C., Rosenfalck A. M., Dejgaard A., Hilsted J. Impaired first‐phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes. Scand J Clin Lab Invest 2007; 67: 327–36
   PubMed Web of Science ®Google Scholar
• Sambol N. C., Chiang J., O'Conner M., Lui C. Y., Lin E. T., Goodman A. M., et al. Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin‐dependent diabetes mellitus. J Clin Pharmacol 1996; 36: 1012–21
   PubMed Web of Science ®Google Scholar
• Cozma L. S., Luzio S. D., Dunseath G. J., Langendorg K. W., Pieber T., Owens D. R. Comparison of the effects of three insulinotropic drugs on plasma insulin levels after a standard meal. Diabetes Care 2002; 25: 1271–6
   PubMed Web of Science ®Google Scholar
• Perriello G., Pampanelli S., Porcellati F., Avogaro A., Bosi E., Petrella G., et al. Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double‐blind and cross‐over trial. Diabet Med 2005; 22: 606–11
   PubMed Web of Science ®Google Scholar
• Hirsch I. B. Insulin analogues. N Engl J Med 2005; 352: 174–83
   PubMed Web of Science ®Google Scholar
• Gredal C., Rosenfalck A. M., Dejgaard A., Hilsted J. Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes. Diabetes Res Clin Pract 2008
   PubMed Web of Science ®Google Scholar
• Mastrototaro J. J. The MiniMed continuous glucose monitoring system. Diabetes Technol Ther 2000; 2( Suppl 1)S13–18
   PubMedGoogle Scholar
• Gross T. M., Mastrototaro J. J. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther 2000; 2( Suppl 1)S19–26
   PubMedGoogle Scholar
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care. 2000; 23( Suppl 1)S4–19
   Google Scholar
• Dixon J. R., Jr. The International Conference on Harmonization Good Clinical Practice guideline. Qual Assur 1998; 6: 65–74
   PubMedGoogle Scholar
• Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C. Homeostasis model assessment – insulin resistance and beta‐cell function from fasting plasma‐glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–19
   PubMed Web of Science ®Google Scholar
• Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 2006; 23: 579–93
   PubMed Web of Science ®Google Scholar
• Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia Diabetes Care. 2005; 28: 1245–9
   Google Scholar
• Praet S. F., Manders R. J., Meex R. C., Lieverse A. G., Stehouwer C. D., Kuipers H., et al. Glycaemic instability is an underestimated problem in Type II diabetes. Clin Sci Lond 2006; 111: 119–26
   PubMed Web of Science ®Google Scholar
• Monnier L., Benichou M., Charra‐Ebrard S., Boegner C., Colette C. An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives. Diabetes Metab 2005; 31: 101–9
   PubMed Web of Science ®Google Scholar
• Monnier L., Colette C., Dunseath G. J., Owens D. R. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 2007; 30: 263–9
   PubMed Web of Science ®Google Scholar
• Ceriello A. Impaired glucose tolerance and cardiovascular disease: the possible role of post‐prandial hyperglycemia. Am Heart J 2004; 147: 803–7
   PubMed Web of Science ®Google Scholar
• Meigs J. B., Nathan D. M., D'Agostino R. B. Sr., Wilson P. W. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002; 25: 1845–50
   PubMed Web of Science ®Google Scholar
• Abrahamson M. J. Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context. Arch Intern Med 2004; 164: 486–91
   PubMed Web of Science ®Google Scholar
• Hay L. C., Wilmshurst E. G., Fulcher G. Unrecognized hypo‐ and hyperglycemia in well‐controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol Ther 2003; 5: 19–26
   PubMedGoogle Scholar